Virtual: Updates in Treatment of Ovarian Cancer: PARP Inhibitors

PARP Inhibitors are a type of targeted cancer drug. New data from clinical trials suggests that they can be helpful when treating ovarian cancer. Join Dr. Elena Moore as she discusses the new data on PARP inhibitors and ovarian cancer, as well as the possible side effects.

Presented by: Elena Moore, MD, Gynecologic Oncology, NorthShore University HealthSystem

Please note:

*Registration ends at noon on November 9th

*Log in will be available 15 minutes prior to program start time.

* An email with the registration link and instructions will be sent the evening before the program